Trials / Completed
CompletedNCT06319859
Intrathecal Non-preservative-free Morphine With Bupivacaine Versus Intrathecal Bupivacaine Alone for Analgesia in Unilateral Inguinal Hernia Repair Surgeries
Intrathecal Non-preservative-free Morphine With Bupivacaine Versus Intrathecal Bupivacaine Alone for Analgesia in Unilateral Inguinal Hernia Repair Surgeries: A Randomized Controlled Clinical Trial.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy and safety of intrathecal non-preservative-free morphine and its effect on pain in patients undergoing unilateral inguinal hernia surgeries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Morphine | The patients will receive 0.1 mg morphine with 15 mg heavy bupivacaine intrathecally |
| DRUG | Placebo | The patients will receive 15 mg heavy bupivacaine with 0.1 ml saline intrathecally |
Timeline
- Start date
- 2024-08-03
- Primary completion
- 2025-10-15
- Completion
- 2025-11-25
- First posted
- 2024-03-20
- Last updated
- 2025-12-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06319859. Inclusion in this directory is not an endorsement.